Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate

24 Sept 2021

Abstract excerpt

Alzheimer’s disease (AD) is the most frequent cause of neurodegenerative dementia and affects nearly 50 million people worldwide. Early stage diagnosis of AD is challenging, and there is presently no effective treatment for AD. The specific genetic alterations and pathological mechanisms of the development and progression of dementia remain poorly understood. Therefore, identifying essential genes and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34683848
DOI: 10.3390/pharmaceutics13101555

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic CandidatePMID 34683848Read ↗

Systematic Analysis and Biomarker Study for Alzheimer’s DiseaseSemantic proximity Read ↗

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity Read ↗

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics AnalysisSemantic proximity Read ↗

Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

Network Pharmacology and molecular docking approach to unveil the mechanism of <i>Hypericum perforatum</i> in the management of Alzheimer’s disorderSemantic proximity Read ↗

Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.Semantic proximity Read ↗

Identification of candidate biomarkers and signaling pathways associated with Alzheimer's disease using bioinformatics analysis of next generation sequencing data and molecular docking studiesSemantic proximity Read ↗

Construction and evaluation of Alzheimer’s disease diagnostic prediction model based on genes involved in mitophagySemantic proximity Read ↗

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysisSemantic proximity Read ↗

Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer’s DiseaseSemantic proximity Read ↗

Diagnostic models and predictive drugs associated with cuproptosis hub genes in Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.